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with conventional multiport laparoscopy
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Jonas Busch1, Dirk Boehmer2, Kurt Miller1 and T Florian Fuller1Abstract
Background: In patients with localized high-risk prostate cancer awaiting radiation therapy, pelvic lymphadenectomy
(PL) is a reliable minimally invasive staging procedure. We compared outcomes after laparoendoscopic single site PL
(LESSPL) with those after conventional multiport laparoscopic PL (MLPL).
Methods: A retrospective case-control study was carried out at the authors’ center. For LESSPL the reusable X-Cone
single port was combined with straight and prebent laparoscopic instruments and an additional 3 mm needlescopic
grasper. MLPL was performed via four trocars of different sizes using standard laparoscopic instruments.
Results: Patients who underwent either LESSPL (n = 20) or MLPL (n = 97) between January 2008 and July 2013,
were included in the study. Demographic data were comparable between groups. Patients in the LESSPL group
tended to be older and had a significantly higher ASA-score. The mean operating time was 172.4 ± 34.1 min for
LESSPL and 116.6 ± 40.1 min for MLPL (P < .001). During LESSPL, no conversion to MLPL was necessary. An average
of 12 lymph nodes per patient was retrieved, with no significant difference between study groups. Postoperative
pain scores were similar between groups. The hospital stay was 2.3 ± 0.7 days after LESSPL and 3.1 ± 1.2 days after
MLPL (P = .01). Two days postoperatively, significantly more patients after LESSPL than after MLPL recovered their
normal physical activity (P < .001). Six months postoperatively, no complications were registered in the LESSPL
group and cosmetic results were excellent.
Conclusions: In the present study, shorter hospitalization and quicker postoperative recovery were major benefits
of LESSPL over MLPL. In patients with localized prostate cancer, staging LESS pelvic lymphadenectomy may be a
safe alternative to conventional multiport laparoscopy.
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In patients with localized high-risk prostate cancer (T1-T3,
PSA ≥20 ng/ml, Gleason score ≥7) suited for radiation
therapy, staging lymphadenectomy is recommended by the
German Society of Radiooncology (DEGRO; www.degro.
org). According to the S3 consensus guidelines of the* Correspondence: frank.friedersdorff@charite.de
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article, unless otherwise stated.DEGRO, pelvic lymph node dissection in prostate cancer
patients helps to detect systemic disease and may therefore
serve as therapeutic decision guidance. A minimum yield
of 10 lymph nodes per patient along both external iliac
arteries and the obturator fossae are recommended.
Since laparoscopic pelvic lymphadenectomy represents
a surgical procedure for merely diagnostic purposes,
complications should be infrequent and recuperation
should be quick. In recent years, laparoendoscopic single
site surgery (LESS) has evolved as an advanced laparo-
scopic technique. It is based upon the idea of solelyntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
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ports, thus minimizing tissue trauma. LESS was initially
described in 1999 [1]. In 2011, Kaouk et al. reviewed more
than 1000 urologic LESS cases that had been performed
worldwide, mainly in high-volume academic institutions
[2]. The application of LESS in urology encompasses a
wide range of procedures, including pelvic lymphadenec-
tomy in males with localized high-risk prostate cancer
[3-7]. According to a few comparative studies, laparo-
endoscopic single-site surgery (LESS) may yield better
postoperative outcomes compared with conventional
multiport laparoscopic surgery [8-10].
In our department LESS pelvic lymphadenectomy
(LESSPL) is carried out with the reusable X-Cone single
port platform via the umbilicus (Karl Storz, Tuttlingen,
Germany). We hypothesized that patient outcomes after
LESSPL, performed with the X-Cone single port are
superior to those after multiport laparoscopic pelvic
lymphadenectomy (MLPL) performed via four laparo-
scopic trocars in the lower abdomen.
Methods
All patient enrolled in this single-center retrospective
case-control study were screened and followed by the
Departments of Urology and Radiation Therapy, Charité
University Hospital, Berlin, Germany. Both institutions are
members of the Charité Comprehensive Cancer Center,
Berlin, Germany. Using our institution’s electronic database,
a total of 117 patients with localized high-risk prostate
cancer, who underwent laparoscopic staging lymphade-
nectomy before radiation therapy were identified. Between
Mai 2011 and July 2013, 20 patients underwent LESS
pelvic lymphadenectomy (LESSPL), whereas 97 patients
underwent conventional multiport laparoscopic pelvic
lymphadenectomy (MLPL) between January 2008 and
April 2013. After Mai 2011, MLPL was performed in case
the experienced LESS surgeon (T.F.F.) was unavailable.
Postoperative parameters were collected by a standard-
ized questionnaire. After screening for patient privacyFigure 1 Transumbilical introduction of the two single port half shell
5 working channels (right).issues, the questionnaire and the study were approved by
the local Ethics Committee at Charité University Hospital
Berlin (EA1/112/12). All patients provided written in-
formed consent for this research study. Written informed
patient consent to publish their image was obtained.
Before transfer to the recovery room, all patients were
given 0.2 mg fentanyl and 2 g metamizole for early post-
operative analgesia. If needed, 1 g paracetamol i.v. was
given during the recovery phase. After transfer to the
urology ward, metamizole was continued on patient’s
request. The dosage was weight adapted with a max-
imum of 4 grams of metamizole per patient per day.
Pain on postoperative day 1 was assessed by using the
numerical analog scale (NAS) as a pain score: a value of
0 indicating no pain and a value of 10 indicating most
severe pain. Full recovery of normal physical activity,
defined as the ability to carry out routine daily tasks
(eating, ambulating, toileting, bathing and dressing) with
no need for pain medications, was evaluated on postoper-
ative day 2. The cosmetic outcome and the incidence of
complications were evaluated 6 months postoperatively.
Surgical techniques
Surgical equipment and setup of the reusable X-Cone
single port
A detailed description, of the use of the X-Cone single port
platform (Karl Storz, Tuttlingen, Germany) has previously
been published [10,11]. In brief, LESSPL was performed
with both surgeons at the same side of the table and the
patient being placed in a supine low lithotomy position. A
periumbilical incision was made to reach the abdominal
space. The surgeon gently introduced the two L-shaped
steel half shells of the X-Cone to form an autostatic X-
shaped funnel, measuring 2.5 cm at its narrow end
(Figure 1). The X-Cone was sealed with a silicone rubber
cap, offering one 14 mm and four 5 mm working channels
(Figure 1). From the existing armamentarium of differently
shaped and prebent laparoscopic instruments (i.e. Carus,
Cuschieri, Leroy) we chose the rigid Carus grasper (S-s (left). X-Cone fully assembled with a reusable silicone cap, providing
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together with a straight laparoscopic scissors and a 5 mm
extra-long 30° telescope (Karl Storz, Tuttlingen, Germany).
A straight 3 mm needlescopic grasper (Karl Storz,
Tuttlingen, Germany) was routinely used via an additional
subumbilical trocar (Figure 2). According to the current
nomenclature, adding an extra needlescopic instrument
transforms LESS into needlescopic-assisted or hybrid
LESS [12].Surgical steps of hybrid LESS pelvic lymphadenectomy
An experienced urologic laparoscopist (T.F.F.) performed
LESSPL. Towards the end of the initial learning curve, a
urologic fellow performed LESSPL on one side, whenever
appropriate. Cases were then completed by the experi-
enced laparoscopist. On each side a peritoneal incision
was used to expose the external iliac vessels and the
obturator nerve as important anatomical landmarks. At
first, lymphatic tissue along the external iliac artery was
mobilized by blunt and sharp dissection. Excellent expos-
ure of the iliac fossa is achieved by static retraction of the
lower margin of the external iliac vein using the prebent
Carus grasper. All 5 mm instruments including the
prebent grasper were inserted transumbilically via the X-
Cone. Introduction of an additional 3 mm needlescopic
grasper via a subumbilical port (Figure 2) provided tri-
angulation ofinstruments, thus improving maneuverability
and safety. All lymphatic tissue along the obturator nerve
was carefully dissected and removed using a 5 mm scis-
sors and a 3 mm grasper. After retrieval of the specimen
via the umbilical incision, the fascia and skin were closed
using absorbable sutures.x1: X-Cone  single port 
x2: 3 mm trocar 
Figure 2 Trocar placement in LESSPL (left) and multiport PL (right).Multiport laparoscopic pelvic lymphadenectomy
Fifteen urologic laparoscopists with different levels of
expertise performed MLPL. The surgical steps hereof
were identical to those described for LESSPL. Two
10 mm and two 5 mm trocars were placed in the lower
abdomen (Figure 2). One 10 mm transumbilical trocar
was used for the 0° telescope (Karl Storz, Tuttlingen,
Germany). Another 10 mm trocar, placed in the midline
below the umbilicus, was used for dissection and speci-
men extraction (Figure 2).
Statistical analysis
SPSS 19.0 for Windows (SPSS Inc.; Chicago IL) was used
for statistical analysis. For comparison of means ± standard
deviation of continuous variables between the two study
groups, the Student’s t-test was employed. Frequency
data were compared between groups by the chi-square
and Fisher’s exact test. Two-sided P values were reported.
A P-value of less than .05 was considered statistically
significant.
Results
Patient characteristics are shown in Table 1. Patients
in the LESSPL group tended to be older and had a sig-
nificantly higher American Society of Anesthesiologists
(ASA)-score, suggesting reduced physical fitness. Pre-
operative oncologic specifications, including the PSA
value and Gleason sum, were indicative of high risk
prostate cancer in both study groups. In all patients,
preoperative metastatic disease was excluded with a
negative bone scan.
The average operating time was significantly longer in
the LESSPL group (172.1 ± 34.1 min) than in the MLPLx1/x4: 10 mm trocars 
x2/x3: 5 mm trocars 












71.8 (±4.2) 69.2 (±5.6) .06
ASA-Scorea
(mean ± SD)
2.5 (±0.5) 2.1 (±0.6) .01*
BMI (kg/m2) 27.3 (±3.4) 27.7 (±4.0) .70
Preoperative
PSA value (ng/ml)
44.7 (±83.5) 32.3 (±56.2) .50
Gleason sum 7.7 (±0.9) 7.7 (±1.0) 1.0
aAmerican Society of Anesthesiologists physical status classification system.
*statistically significant.
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sions from LESSPL to MLPL were necessary and blood
loss was minimal in all patients. The average number of
retrieved lymph nodes (n =12) and the proportion of
patients with positive lymph nodes (31%) was equally
distributed among groups.
In the LESSPL group, the length of hospital stay was
significantly shorter than in the MLPL group (2.3 ±
0.7 days vs. 3.1 ± 1.2 days; P = .01). Pain scores on day 1,
tended to be lower in the LESSPL group, but differences
did not reach statistical significance: 2.5 ± 2.0 vs. 3.2 ± 1.7,
respectively. By day 2, a significantly higher proportion of
patients in the LESSPL group than in the MLPL group
reported return to normal physical activity (84% vs. 32%;
P < .001). All patients in the LESSPL group reported full
satisfaction with the cosmetic outcome (Figure 3), whereas
95% of patients after MLPL were fully satisfied with cosm-
esis (P = .58).
No intra or postoperative complications occurred in the
LESSPL group, whereas 23 out of 75 patients (31%) in
the MLPL group experienced complications. In one pa-
tient intraoperative bladder injury required intracorporeal
suturing and urine drainage for several days. PostoperativeTable 2 Postoperative outcomes
Total operating time (min)
No. retrieved lymph nodes per patient
No. patients with positive nodes
Hospital stay (days)
Pain score (NAS) postop. day 1
No. patients with full recovery of normal physical activity by postop. day 2
No. patients with complications
No. patients fully satisfied with cosmetic result
anumerical analog scale (NAS): 0 = no pain; 10 =most severe pain.
bmissing data: n =1 patient (LESSPL); n =22 patients (MLPL).
*statistically significant.complications included chronic abdominal pain, reversible
paresthesia of the upper thigh, hematoma, lymphoedema,
wound infection (Clavien Grade 1; n =18 patients) and
deep vein thrombosis (Clavien grade 2; n =1 patient).
One patient with a port site hernia and 3 patients with
a lymphocele required surgical intervention (Clavien
grade 3; n =4 patients).
Figure 4 shows the evolution of total operating time in
16 selected patients undergoing LESSPL. Operating times
are divided into two groups: the experienced laparosco-
pist’s initial LESSPL learning curve and subsequent
teaching cases. Four patients were excluded. In one
patient the surgery was stopped after a lymph node metas-
tasis was detected upon frozen section. In 3 patients, oper-
ating times were prolonged based on technical problems,
including C02 leakage or malfunction of laparoscopic
instruments.
Discussion
Trocars used for conventional laparoscopy measure be-
tween 5 mm and 12 mm in diameter. The use of multiple
trocars in the mid or lower abdomen may leave behind
visible scars, thus compromising the cosmetic outcome.
Laparoendoscopic single site surgery (LESS) typically uses
the umbilicus for insertion of instruments and for speci-
men extraction via a larger single port. The advantage of
the umbilical access is a relatively hidden and thus cos-
metically favourable scar, even though the incisional
length is longer than that of a conventional 12 mm trocar
(Figure 3). According to the literature, umbilical hernias
after single port surgery occur in less than 1% of cases
[13,14]. In our present LESSPL series, no wound compli-
cations occurred within 6 months of follow-up.
Over the past years, LESS has gained popularity in vari-
ous surgical disciplines. In abdominal surgery, significant
clinical benefits of LESS over conventional laparoscopy
have not yet been proven [15-17]. In selected adult
urologic procedures, i.e. living donor nephrectomy andLESSPL (LESS pelvic
lymphadenectomy) n = 20
MLPL (Multiport pelvic
lymphadenectomy) n = 97
P value
172.1 (±34.1) 116.6 (±40.1) < .001*
12.5 (±5.1) 12.2 (±6.2) .87
7/20 (35%) 29/97 (30%) .79
2.3 (±0.7) 3.1 (±1.2) .01*
2.5a (±2.0) 3.2a (±1.7) .12
16/19b (84%) 24/75b (32%) < .001*
0/19b (0%) 23/75b (31%) .01*
19/19b (100%) 71/75b (95%) .58
Figure 3 Abdominal scars 6 months after LESSPL.
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and accelerated postoperative recovery as compared to
conventional laparoscopy [9,10,18]. In staging lymphade-
nectomy for endometrial cancer, outcome parameters after
LESS were comparable to those after conventional multi-
port laparoscopy [8,19]. One group, however, reported
significantly reduced pain scores after LESS surgical sta-
ging for endometrial cancer [20].
We herein investigated potential benefits of LESS over
conventional laparoscopy for surgical staging in high-risk
prostate cancer patients awaiting radiation therapy. For
comparison of LESS with conventional multiport laparos-
copy we used a monocentric retrospective case-control
study in an academic teaching environment. For the first
time we showed that, apart from a significantly longer
total operating time, the length of hospitalization as well
as recovery of normal physical activity after pelvic lymph-
adenectomy was significantly shorter in the LESSPL group
compared with the multiport laparoscopy group (MLPL).
Moreover, the incidence of intra and postoperative com-
plications was 0% in the LESSPL group and 30% in the
MLPL group within 6 months of follow up. The average
yield of pelvic lymph nodes per patient was 12.4, with no
statistically significant difference between the two cohorts.Figure 4 Evolution of total operating time in 16 patients undergoingIn a large study on multiport laparoscopic lymph node
dissection for prostate cancer, comparing the extended
and modified techniques, authors reported lymph node
yields of 17.8 and 9.3, respectively [21]. Given its high effi-
ciency and low morbidity compared with the extended
technique, modified laparoscopic pelvic lymphadenec-
tomy, involving the obturator and hypogastric nodes is the
preferred method for prostate cancer staging [21].
A total of 15 urologic surgeons with different levels of
laparoscopic expertise performed MLPL, whereas only
one experienced laparoscopist carried out LESSPL. This
may contribute to the lower complication rate observed
in the LESSPL group. All complications in the MLPL
group were seen after discharge from hospital. It is,
therefore, unlikely that longer hospitalization and slower
recovery of physical activity early after MLPL may be
linked to the higher complication rate in this group.
Rather was reduced postoperative pain responsible for
quicker recovery and shorter hospitalization in the
LESSPL group. Despite a trend in favor of the LESSPL
group, differences in postoperative pain scores between
groups were not statistically significant. Preoperative
physical fitness was assessed by the American Society of
Anesthesiologists (ASA)-score. Patients in the LESSPLLESSPL.
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significantly higher ASA-score, indicative of reduced
physical fitness (Table 1).
In a recent article by Liedberg et al. on the benefits of
multiport laparoscopic pelvic lymphadenectomy in pros-
tate cancer patients, the incidence of Clavien grade 2
and 3 complications was 10.5% [22]. In comparison, the
incidence of Clavien grade 2 and 3 complications in
patients who underwent MLPL at our institution was 6%.
In the context of the literature, our MLPL group proved
to be a valid control group for the comparison with
LESSPL. In our present work, no postoperative complica-
tions occurred within 6 months after LESSPL. In a series
of 15 consecutive LESSPL in males with localized high risk
prostate cancer, Schwentner et al. reported on one patient
with inadvertent bowel injury, requiring intracorporal
suturing [11]. In our view, patient safety should be a major
issue in a pure diagnostic staging procedure, especially
when a novel minimally invasive technique is used.
In our study, trainee involvement may have contributed
to increased operative time, since MLPL and in part also
LESSPL, were used to provide laparoscopic training to
urology fellows. Recently, Rais-Bahrami et al. proposed
that LESS training should be incorporated into the laparo-
scopic training program of urology residents and fellows.
Establishing a credential process for LESS should be
strongly considered by accrediting bodies [23].
The lack of triangulation and overcrowding of laparo-
scopic instruments not only accounts for a slow learning
curve in almost all LESS procedures, but may also com-
promise patient safety. To overcome the lack of triangu-
lation, instruments with flexible tips are increasingly used
in single port surgery. In most cases, these instruments
are disposable and therefore reduce cost effectiveness of
LESS [9,24]. For LESSPL, we favor a totally reusable single
port platform (X-Cone, Karl Storz, Tuttlingen, Germany)
with conventional straight and rigid prebent laparoscopic
instruments. In our view, adding an extra 3 mm port for a
needlescopic instrument improves triangulation and sur-
geon dexterity during LESSPL, without compromising the
overall cosmetic outcome (Figure 3). Furthermore, it helps
to reduce instrument overcrowding in the single port.
According to the current nomenclature, “needlescopic-
assisted” LESSPL performed in the present study should
correctly be denoted “hybrid LESS” [12].
The majority of LESS platforms currently available on the
market use disposable components. In an earlier publica-
tion, we estimated cumulative cost of 10 LESS procedures,
performed with different single ports, and identified the
reusable X-Cone as being the most cost-effective [10]. In
their recent publication on different urologic LESS proce-
dures, Schwentner et al. found that LESS nephrectomy
performed with the X-Cone is more cost-effective than
conventional multiport laparoscopic nephrectomy [11].Limitations of our present work include the relatively
small number of cases in the LESSPL group and the mono-
centric, retrospective design of the study. The laparoscopic
procedures herein described are embedded in an academic
training program. Thus, the relatively high number of par-
ticipating surgeons and the inconsistency of laparoscopic
expertise across study groups, i.e. one surgeon performing
LESS vs. 15 surgeons performing multiport laparoscopy,
represent a bias. Length of hospitalization as an outcome
measure could have been biased by the fact that early dis-
charge in the LESSPL group was probably promoted more
aggressively by the medical staff than in the MLPL group.
However, all patients in the LESSPL group were free to
prolong their hospital stay as needed.Conclusions
In conclusion, our present study demonstrates that staging
pelvic lymphadenectomy for prostate cancer, performed
by laparoendoscopic single site surgery (LESS) is feasible
and safe in the hands of an experienced urologic laparos-
copist. Given its reusable components, the X-Cone single
port platform is cost-effective. Compared with conven-
tional multiport laparoscopy, LESS offers quicker postop-
erative recovery of prostate cancer patients awaiting
radiation therapy for localized disease. Despite its limi-
tations, our study provides the basis for prospective
randomized trials to further evaluate the benefits of LESS
in urology and cognate disciplines.Abbreviations
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